Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...

ACA Pharma: team@acapharma.net Azurity Pharmaceuticals: media@azurity.com ...

Simulations reveal details about the magnetic interactions between gadolinium contrast agents used in MRI scans and their environment. You can keep your best guesses. Engineers at Rice University's ...

Camberley nurse Clare Garrett, 45, says she was left needing a wheelchair after she had a private MRI scan in June 2024 following an accident at her home ...

Qualitative ratings showed non-significant differences between the proposed method – a 10% level of gadolinium dose – and acquired full-dose contrast-enhanced MRI images, which was also verified with ...

A new study has shown that artificial intelligence could be used to dramatically reduce the amount of gadolinium used in MRI scans. The findings, which are being presented today at the annual meeting ...

January 2, 2007 — The US Food and Drug Administration (FDA) warned healthcare professionals last week about additional reports of nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy ...

Gadopiclenol carries a Boxed Warning associated with an increased risk of nephrogenic systemic fibrosis among patients with impaired elimination of the drugs. The approval of gadopiclenol was based on ...

Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems, according to a study performed at the ...